- Consequences of electrocardiography screening for prolonged QTc in neonates - A systematic review
- Generation of human induced pluripotent stem cell (hiPSC) lines from patients with extreme high and low polygenic scores for QT interval
- LncRNA MALAT1/Calpain-1 Axis in ATO Induced hERG Channel Deficiency
- Fetal arrhythmias: Current evidence of prenatal diagnosis and management
- Drug-induced long QT syndrome: Concept and nonclinical models for predicting the onset of drug-induced torsade de pointes in patients in compliance with International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) E14/S7B guidance
- The association between insulin resistance and QT interval: A systematic review and Meta-Analysis
- Genome-Wide Association Study for Resting Electrocardiogram in the Qatari Population Identifies 6 Novel Genes and Validates Novel Polygenic Risk Scores
- A 4-Day Exposure to High Altitude Prolongs QTc in Healthy Human Subjects
- Screening of 1-Month-Old Infants With Prolonged QT Interval and Its Cutoff Value
- Managing long QT syndrome patients, cooking, and common sense
- Calibrated Functional Data Decreases Clinical Uncertainty for Tier 1 Monogenic Disease: Application to Long QT Syndrome
- Voltage Sensor Conformations Induced by LQTS-associated Mutations in hERG Potassium Channels
- A privileged ER compartment for post-translational heteromeric assembly of an ion channel
- Effect of a Supratherapeutic Dose of Omaveloxolone on the Corrected QT Interval in Healthy Participants: A Randomized, Double-Blind, Placebo- and Active-Controlled, Three-Way Crossover Study
- Out-of-Hospital Cardiac Arrest in Apparently Healthy, Young Adults
- SCN5A missense variants and their contribution to deaths in Sudden Unexplained Nocturnal Death Syndrome (SUNDS)
- Surveillance of QTc-Interval Prolonging Medications Upon Admission Throughout Hospitalization in a Tertiary Care Geriatric Ward
- Low Proarrhythmic Risk of Imetelstat, a Novel Oligonucleotide Telomerase Inhibitor: A Translational Analysis
- Human induced pluripotent stem cell-cardiomyocytes for cardiotoxicity assessment: a comparative study of arrhythmiainducing drugs with multi-electrode array analysis
- Cardiac Neuromodulation and Neurocardiology
- Novel mutation in KCNJ2 gene causes long QT interval syndrome type 7 and learning disability: A case report
- Integrative analysis of KCNQ1 variants reveals molecular mechanisms of type 1 long QT syndrome pathogenesis
- Exploring the association of natriuretic peptides with QTc interval in hemodialysis patients
- Self-limited familial focal epilepsy caused by ANK2 variants: A potentially under-recognized condition
- "Better Late Than Never"-Late-Onset Genotype-Negative Congenital Long QT Syndrome: Case Report and Review
- Heart Disease in Children: Cardiac Dysrhythmias
- Syncope Linked to QT-Interval Prolongation and Global T-Wave Inversion: A Clinical Case of Acute Pulmonary Embolism
- Genetic Background and Clinical Phenotype in an Italian Cohort with Inherited Arrhythmia Syndromes and Arrhythmogenic Cardiomyopathy (ACM): A Whole-Exome Sequencing Study
- Synaptic plasticity deficits in a mouse model of Timothy syndrome: LTP saturation and its pharmacological rescue by nifedipine
- Acute psychosis after "puff bar" use
- The association of NOS1AP gene polymorphisms with the duration of the QT interval in patients with schizophrenia receiving antipsychotic therapy
- Long QT syndrome type 3 gain-of-function of Na(v)1.5 increases ventricular fibroblasts proliferation and pro-fibrotic factors
- Primary diagnosis of atrioventricular pseudo-block in a neonate with definitive diagnosis of long QT syndrome: diagnostic considerations and therapeutic approaches
- Congenital Long QT Syndrome Type 7: Diagnostic Challenge Bridged by Genetic Testing
- New emerging T-wave inversion in an elderly patient after atrial fibrillation ablation
- Topological Distribution of KCNH2 Variants and Genotype-Phenotype Relationship in Patients With Long QT Syndrome
- What Lies Beneath: Provoking the QT to Identify Risk in Long QT syndrome
- Effect of the Membrane Environment on Pharmacologic Inhibition of hERG K+ Channel Activity
- Effect of the Membrane Environment on Pharmacologic Inhibition of hERG K+ Channel Activity
- Effect of the Membrane Environment on Pharmacologic Inhibition of hERG K+ Channel Activity
- Effect of the Membrane Environment on Pharmacologic Inhibition of hERG K+ Channel Activity
- Effect of the Membrane Environment on Pharmacologic Inhibition of hERG K+ Channel Activity
- Effect of the Membrane Environment on Pharmacologic Inhibition of hERG K+ Channel Activity
- Effect of the Membrane Environment on Pharmacologic Inhibition of hERG K+ Channel Activity
- Effect of the Membrane Environment on Pharmacologic Inhibition of hERG K+ Channel Activity
- Effect of the Membrane Environment on Pharmacologic Inhibition of hERG K+ Channel Activity
- Effect of the Membrane Environment on Pharmacologic Inhibition of hERG K+ Channel Activity
- Effect of the Membrane Environment on Pharmacologic Inhibition of hERG K+ Channel Activity
- Effect of the Membrane Environment on Pharmacologic Inhibition of hERG K+ Channel Activity
- Effect of the Membrane Environment on Pharmacologic Inhibition of hERG K+ Channel Activity